Seqirus first to reach large-scale manufacture of cell-based influenza vaccines
admin 21st June 2017 Uncategorised 0Seqirus said it has achieved an industry first by producing a cell-based influenza vaccine on a commercial scale using a virus that has been grown in cells versus the traditional method of using chicken eggs.
More: Seqirus first to reach large-scale manufacture of cell-based influenza vaccines
Source: fierce